Knowledge of the clinical outcomes associated with continuous glucose monitor (CGM) use is crucial when creating Medicaid policy that ensures that people with diabetes receive evidence-based care that improves their health and well-being. The resources in this section can help states understand and effectively convey the importance of expanding access to CGMs to improving health outcomes.

Narrow by:
Content Types